Cleveland Alzheimer’s Disease Research Center

New Funding Announcement

The CADRC team is delighted to report that we have received notice from the U.S. National Institute of Aging (NIA) that our center has received support to continue our work for another 5 years. We are deeply grateful to the scientists, patients, families and many other individuals and groups who helped make this possible!

National Institute on Aging Awards
$15.4 Million to Continue Support for
Cleveland Alzheimer’s Disease Research Center

August 24, 2021, CLEVELAND: The National Institute on Aging of the National Institutes of Health (NIH) has awarded a grant expected to total $15.4million to continue funding the Cleveland Alzheimer’s Disease Research Center. The new five-year award will support the multi-institution collaborative, which aims to accelerate research for Alzheimer’s disease and related dementias.

Click here for more information

The Cleveland Alzheimer’s Disease Research Center (CADRC) is a National Institute on Aging Center which has the goal of increasing the speed of research being done on aging-related brain disorders. A key activity of the CADRC is a multi-site, observational study in which older individuals both with and without dementia will be followed over time. Participants will be asked to undergo bio-specimen collection, imaging procedures, and cognitive testing on an annual basis. This readily-available data will be used to advance national-level future research, including therapeutic trials.

On June 7, 2021, the FDA approved aducanumab to treat patients with Alzheimer’s disease .
For more information about this new treatment, please click here.

CADRC Investigator News

Lynn Bekris, PhD, Associate Staff at the Cleveland Clinic Genomic Medicine Institute and leader of the CADRC Biomarker Core, has been awarded a three-year, nearly $300,000 grant from the Aging Mind Foundation to study inflammatory factors involved in the early stages of Alzheimer’s disease (AD) in order to better understand the underlying cause of AD and inform novel therapeutic strategies.
Photo of Andrew Pieper
Andrew Pieper MD
Translational Therapeutics Core Leader

“There is a growing body of evidence in the field that Alzheimer’s disease develops much earlier than previously thought, most likely decades before our current ability to clinically diagnose the condition,” said study co-author Andrew A. Pieper.

New Alzheimer’s disease pathway discovered, providing earlier target for potential therapies – The Daily

“Our goal is to provide supportive intervention for those caring for someone with dementia, particularly during these transitional periods of caregiving for persons with dementia,” Zauszniewski said.

Nursing’s Jaclene Zauszniewski awarded $2.6M grant to study stress management in caregivers of people with dementia – The Daily

Jaclene A. Zauszniewski, PhD, RN-BC, FAAN
OREC Team Member

Photo of elderly couple and young caregiver walking in the nature

We have a number of exciting opportunities to learn more and get involved

Close up of male carer holding hands of senior woman, home caregiver showing support for elderly patient.

CADRC is a collaboration between Case Western Reserve University, Cleveland Clinic, University Hospitals and the Louis Stokes Cleveland VA Medical Center

For COVID-19 (The Novel Coronavirus) Information for Caregivers please click here.

Para obtener información sobre COVID-19 (El nuevo coronavirus) para cuidadores, haga clic aquí.